Daño por Radicales Libres

Aloe vera is among the most widely used natural supplements for IC; it is rich in GAG-like polysaccharides that may restore the bladder mucosal lining. Survey and open-label studies report 87.5–92% patient response rates. A formal FDA-approved double-blind RCT (NCT04734106, Wake Forest University) is underway to rigorously assess efficacy.

Intravesical capsaicin has been clinically tested for interstitial cystitis/bladder pain syndrome (IC/BPS), exploiting TRPV1-mediated C-fiber desensitization to reduce bladder pain and neurogenic inflammation. Clinical trials exist but results have been inconsistent; the American Urological Association recommends against the analogous resiniferatoxin instillation.

Chondroitin sulfate is a major GAG component of the bladder's protective urothelial lining and has been studied both intravesically and orally for IC. As part of CystoProtek, oral chondroitin sulfate (600 mg/day) reduced symptom severity in a 252-patient uncontrolled trial of refractory IC patients; intravesical chondroitin has also shown benefit in pilot studies.

Glucosamine is a natural GAG precursor used to help repair the bladder's defective protective mucosal layer in IC. As part of CystoProtek (480–600 mg glucosamine sulfate/day), it was studied in an uncontrolled trial of 252 IC/BPS refractory patients, showing reduced symptom severity over more than 12 months of monitoring.

Glycosaminoglycans (GAGs) directly address the primary recognized pathology of IC/BPS — dysfunction of the bladder's protective GAG urothelial layer. Intravesical GAG therapies (hyaluronic acid, chondroitin sulfate) show up to 85% improvement rates, and oral multi-agent GAG supplements produced significant symptom reduction in a 252-patient uncontrolled trial (Theoharides et al., Can J Urol 2008).

Hyaluronic acid (hyaluronate) is a natural GAG with the longest evidence base in IC, primarily via intravesical instillation (standard therapy in Europe and Canada, with up to 85% improvement rates). Oral hyaluronate (40 mg/day) has also been trialed as part of multi-agent CystoProtek in 252 refractory IC patients with significant symptom improvement.

L-arginine, the substrate for nitric oxide synthase (NOS), has been trialed for IC because NOS activity is reduced in IC urine. Multiple open-label trials and one randomized double-blind placebo-controlled trial (Korting et al., J Urol 1999) found benefit in a subset of IC patients at 1,500 mg/day for 3 months, though a crossover RCT produced mixed results.

N-Acetyl-Glucosamine (NAG) is the direct monomeric building block for hyaluronic acid and other GAGs that form the bladder's protective mucosal layer. NAG is specifically described in patented GAG-replacement compositions for IC as acting to link the supramolecular GAG complex and as a precursor for new GAG chain synthesis by existing bladder tissue.

Micronized PEA combined with polydatin (Pelvilen Forte) was tested in a pilot open-label bicentric study (Cervigni et al., Biomed Res Int 2019; PMC6885282) in 32 refractory IC/BPS patients over 6 months; a significant and progressive pelvic pain reduction (p<0.0001) and improvements in validated IC symptom questionnaire scores were observed.

Pine bark extract (Pycnogenol, 150 mg/day) was studied in a published open pilot registry trial (Ledda et al., Evid Based Complement Alternat Med 2021; PMID 34257695) in 64 subjects with recurrent UTI or IC; compared with cranberry extract and standard management, Pycnogenol produced a 62% reduction in UTI/IC episode rate and 91% elimination of symptoms over 2 months.

Polydatin (a natural precursor of resveratrol) was co-administered with micronized PEA in a 6-month pilot open-label bicentric study (Cervigni et al., Biomed Res Int 2019; PMC6885282) in 32 refractory IC/BPS patients, demonstrating significant and progressive pelvic pain reduction (p<0.0001) and improved validated IC symptom questionnaire scores.

Quercetin has the strongest direct clinical evidence among natural supplements for IC. An open-label trial (Katske et al., Tech Urol 2001) in 22 IC patients using 500 mg twice daily for 4 weeks showed 19/20 completers had significant improvement in IC symptom and problem indices and global pain scores. It is also the primary anti-inflammatory component of the multi-agent CystoProtek supplement tested in a 252-patient uncontrolled trial.

Rutin is an anti-inflammatory bioflavonoid glycoside co-formulated with quercetin in CystoProtek. In a 252-patient open-label trial (Theoharides et al., Can J Urol 2008), 80 mg rutin/day as part of this multi-agent supplement produced significant IC symptom reduction in refractory patients over more than 12 months.

Corn silk has a documented traditional use for chronic cystitis including interstitial cystitis, attributed to its anti-inflammatory and soothing effects on bladder mucosa and its diuretic action. No clinical trials in humans with interstitial cystitis have been published.

Marshmallow root has been used in traditional Western herbal medicine specifically for interstitial cystitis, with herbalists citing mucilage-mediated coating of the irritated bladder lining as the rationale. It appears in herbal monographs for this indication. Robust human clinical trials for IC are absent; evidence is traditional and mechanistically plausible.

Slippery elm is recommended by herbalists for interstitial cystitis based on its mucilage's proposed ability to coat and soothe the bladder wall. Its use for urinary tract inflammation is documented in Native American medicine. No clinical trials have evaluated it for interstitial cystitis.